TEMECULA, CA -- (MARKET WIRE) -- December 19, 2006 -- CLX Investment Company, Inc. (OTCBB: CLXN), a diversified investment fund, today announced that portfolio investment Zonda, Incorporated has modified the testing procedure for its HandiLab line of medial diagnostic tests for the purpose of making the test easier to perform and allow for better interpretation of the end result.
